Trade ARK Genomic Revolution ETF - ARKG CFD

ARK Genomic Revolution ETF Company profile

ARK Genomic Revolution ETF (ARKG) is an actively managed exchange-traded fund (ETF) that seeks long-term capital growth through investment in the genomics revolution. 

Launched in 2014 by ARK Investment Management LLC, ARKG has $3.69bn of assets under management (AUM).

Under normal circumstances, the fund invests at least 80% of its assets in domestic and foreign equity securities in companies that justify the fund’s theme and focus on enhancing the quality of life with a better lifestyle and increased longevity. 

Coming from various sectors such as healthcare, information technology and materials, these companies incorporate technological and scientific developments in genomics into their businesses.

As of June 2022, the fund’s portfolio had the highest exposure to molecular diagnostics, followed by bioinformatics, beyond DNA, targeted therapeutics, gene therapy and agricultural biology. 

Listed on the Better Alternative Trading System (BATS), ARK Genomic Revolution ETF trades under the ticker symbol ARKG. The fund pays dividends annually. 

You can follow ARKG share value at Capital.com, and stay on top of the latest price developments with our live ARK Genomic Revolution (ARKG) chart.